Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Palmitate and Stearate are Increased in the Plasma in a 6-OHDA Model of Parkinson's Disease

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Neonatal Urine Metabolic Profiling and Development of Childhood Asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Neurotransmitter Imbalance in the Brain and Alzheimer’s Disease Pathology

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Impact of binge drinking on hepatic lipid metabolism: lipidome analysis of liver vein and peripheral blood during acute alcohol intoxication

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  4. Polyols and Branched Chained Amino Acids Are Associated with Present and Future Renal Impairment in Type 1 Diabetes

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations

INTRODUCTION: Parkinson's disease (PD) is the second most common neurodegenerative disorder, without any widely available curative therapy. Metabolomics is a powerful tool which can be used to identify unexpected pathway-related disease progression and pathophysiological mechanisms. In this study, metabolomics in brain, plasma and liver was investigated in an experimental PD model, to discover small molecules that are associated with dopaminergic cell loss.

METHODS: Sprague Dawley (SD) rats were injected unilaterally with 6-hydroxydopamine (6-OHDA) or saline for the vehicle control group into the medial forebrain bundle (MFB) to induce loss of dopaminergic neurons in the substantia nigra pars compacta. Plasma, midbrain and liver samples were collected for metabolic profiling. Multivariate and univariate analyses revealed metabolites that were altered in the PD group.

RESULTS: In plasma, palmitic acid (q = 3.72 × 10-2, FC = 1.81) and stearic acid (q = 3.84 × 10-2, FC = 2.15), were found to be increased in the PD group. Palmitic acid (q = 3.5 × 10-2) and stearic acid (q = 2.7 × 10-2) correlated with test scores indicative of motor dysfunction. Monopalmitin (q = 4.8 × 10-2, FC = -11.7), monostearin (q = 3.72 × 10-2, FC = -15.1) and myo-inositol (q = 3.81 × 10-2, FC = -3.32), were reduced in the midbrain. The liver did not have altered levels of these molecules.

CONCLUSION: Our results show that saturated free fatty acids, their monoglycerides and myo-inositol metabolism in the midbrain and enteric circulation are associated with 6-OHDA-induced PD pathology.

Original languageEnglish
Article number31
JournalMetabolites
Volume9
Issue number2
ISSN2218-1989
DOIs
Publication statusPublished - 13 Feb 2019

    Research areas

  • 6-OHDA, Fatty acid metabolism, GC-MS, Midbrain, Myo-inositol, Parkinson’s disease, Plasma

ID: 56600127